| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.BMT.1705134 |
| P8608 | Fatcat ID | release_jctnsshuongqhfkh3auz2e5v7i |
| P698 | PubMed publication ID | 16151428 |
| P5875 | ResearchGate publication ID | 7611525 |
| P2093 | author name string | Nakagawa M | |
| Oshima K | |||
| Hirai H | |||
| Chiba S | |||
| Izutsu K | |||
| Kurokawa M | |||
| Kanda Y | |||
| Motokura T | |||
| Asano-Mori Y | |||
| Hangaishi A | |||
| Kandabashi K | |||
| Sakata-Yanagimoto M | |||
| P2860 | cites work | Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes | Q31835044 |
| Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 | ||
| Quantitation of cytomegalovirus: methodologic aspects and clinical applications. | Q39468915 | ||
| Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation | Q42169566 | ||
| Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan | Q43583148 | ||
| Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin | Q43891814 | ||
| Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation | Q43914156 | ||
| Endothelial damage caused by cytomegalovirus and human herpesvirus-6. | Q44383243 | ||
| Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease | Q45756791 | ||
| Graft-versus-tumor effect against advanced pancreatic cancer after allogeneic reduced-intensity stem cell transplantation | Q46428232 | ||
| Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. | Q51700168 | ||
| Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant | Q72940232 | ||
| Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial | Q72940234 | ||
| Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin | Q73972876 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| P304 | page(s) | 813-819 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation | |
| P478 | volume | 36 |
| Q36433529 | Acceleration of allograft failure by cytomegalovirus |
| Q34626390 | Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated |
| Q46718682 | Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation |
| Q42275611 | Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients |
| Q40674993 | Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation |
| Q40411962 | Cytomegalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study |
| Q39411854 | Detection of active human cytomegalovirus by the promyelocytic leukemia body assay in cultures of PBMCs from patients undergoing hematopoietic stem cell transplantation |
| Q41099371 | Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation |
| Q35784260 | Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer |
| Q36846740 | Management of cold haemolytic syndrome |
| Q45367721 | Opportunistic virus DNA levels after pediatric stem cell transplantation: serostatus matching, anti-thymocyte globulin, and total body irradiation are additive risk factors. |
| Q57213055 | Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea |
| Q43014781 | The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia |
| Q90377445 | Visual prognosis, clinical features, and predisposing factors in non-HIV patients with cytomegalovirus retinitis |
Search more.